probenecid has been researched along with Alcoholic Fatty Liver in 1 studies
Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iracheta-Vellve, A | 1 |
| Petrasek, J | 1 |
| Satishchandran, A | 1 |
| Gyongyosi, B | 1 |
| Saha, B | 1 |
| Kodys, K | 1 |
| Fitzgerald, KA | 1 |
| Kurt-Jones, EA | 1 |
| Szabo, G | 1 |
1 other study available for probenecid and Alcoholic Fatty Liver
| Article | Year |
|---|---|
Inhibition of sterile danger signals, uric acid and ATP, prevents inflammasome activation and protects from alcoholic steatohepatitis in mice.
Topics: Adenosine Triphosphate; Adjuvants, Pharmaceutic; Allopurinol; Animals; Antimetabolites; Cells, Cultu | 2015 |